Donoghue Forlines’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,602
Closed -$2.96M 103
2025
Q2
$2.96M Buy
+17,602
New +$2.61M 0.84% 13
2021
Q1
Sell
-20,421
Closed -$1.09M 223
2020
Q4
$1.09M Buy
+20,421
New +$1.06M 0.21% 128
2018
Q4
Sell
-255,626
Closed -$13.8M 48
2018
Q3
$13.8M Sell
255,626
-48,511
-16% -$2.48M 1.08% 31
2018
Q2
$14.9M Buy
304,137
+52,669
+21% +$2.99M 1.23% 55
2018
Q1
$15.8M Sell
251,468
-45,797
-15% -$3.14M 1.37% 50
2017
Q4
$18.2M Buy
+297,265
New +$18.4M 1.38% 28

Other funds holding CAH

Donoghue Forlines's CAH Position: Q3 2025 in Review

Donoghue Forlines sold out of Cardinal Health (CAH) in Q3 2025, closing a stake of 17,602 shares — an estimated $2.96M sold.

Donoghue Forlines first reported a position in CAH in Q4 2017 and held it in 6 quarters. The position peaked at $18.2M in Q4 2017. 1,222 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

  • Donoghue Forlines reported no remaining Cardinal Health position as of Q3 2025 after selling out during the quarter.
  • Donoghue Forlines sold 17,602 Cardinal Health shares in Q3 2025, an estimated $2.96M.
  • Donoghue Forlines first reported a position in Cardinal Health in Q4 2017 and held it in 6 quarters.
  • Donoghue Forlines's Cardinal Health position peaked at $18.2M in Q4 2017.
  • 1,222 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Donoghue Forlines's 13F filing for Q3 2025, filed 29 Oct 2025.